⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1765686 | 0.81 | — | — | |
| SCHEMBL582317 | 0.67 | — | — | |
| SCHEMBL27952993 | 0.65 | ALDH1A1 (0.30) | — | |
| SCHEMBL1654101 | 0.65 | — | — | |
| SCHEMBL598853 | 0.64 | TSHR (0.46) | — | |
| SCHEMBL23046 | 0.60 | — | — | |
| SCHEMBL374943 | 0.60 | — | — | |
| SCHEMBL27678783 | 0.60 | — | — | |
| SCHEMBL2399 | 0.60 | — | — | |
| Phosphine SCHEMBL1582212 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4392422-A1 | EIF4E INHIBITORS AND USES THEREOF | PIC Therapeutics, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023028235-A1 | EIF4E INHIBITORS AND USES THEREOF | PIC Therapeutics, Inc. (US) | 2023-03-02 | — | — | WO | disclosed |
| CN-115322238-A | Oxysterol and methods of use thereof | 萨奇治疗股份有限公司 | 2022-11-11 | — | — | CN | disclosed |
| EP-4058439-A1 | 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY | Genzyme Corporation (US) | 2022-09-21 | — | — | EP | disclosed |
| CN-115003659-A | 5-membered heteroaryl amino sulfonamides for the treatment of conditions mediated by a deficiency in CFTR activity | 健赞公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-110072874-B | Oxysterol and methods of use thereof | 萨奇治疗股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-114891056-A | Oxysterol and methods of use thereof | 萨奇治疗股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-9758480-B2 | 1-(cycloalkyl-carbonyl)proline derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| US-9718840-B2 | Condensed 5-oxazolidinone derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-08-01 | — | — | US | disclosed |
| US-20170022218-A1 | CONDENSED 5-OXAZOLIDINONE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-01-26 | — | — | US | disclosed |
| US-20070225267-A1 | 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors | ELI LILLY AND COMPANY | 2007-09-27 | — | — | US | disclosed |
| CN-1968921-A | Glucagon receptor antagonists, preparation and therapeutic uses | LILLY CO ELI (US) | 2007-05-23 | — | — | CN | disclosed |
| EP-1758853-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-03-07 | — | — | EP | disclosed |
| WO-2006086488-A2 | SUBSTITUTED THIOPHENE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006034093-A2 | 3- (2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS | ELLI LILLY AND COMPANY (US) | 2006-03-30 | — | — | WO | disclosed |
| WO-2005123668-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2005-12-29 | — | — | WO | disclosed |
| EP-1077918-B1 | SYNTHESIS AND PURIFICATION OF 3,3-DIMETHYLBUTYRALDEHYDE VIA OXIDATION OF 1-CHLORO-3, 3-DIMETHYLBUTANE WITH DIMETHYL SULFOXIDE | NUTRASWEET CO (US) | 2005-02-23 | — | — | EP | disclosed |
| EP-1077918-A1 | SYNTHESIS AND PURIFICATION OF 3,3-DIMETHYLBUTYRALDEHYDE VIA OXIDATION OF 1-CHLORO-3, 3-DIMETHYLBUTANE WITH DIMETHYL SULFOXIDE | THE NUTRASWEET COMPANY (US) | 2001-02-28 | — | — | EP | disclosed |
| WO-1999059951-A1 | SYNTHESIS AND PURIFICATION OF 3,3-DIMETHYLBUTYRALDEHYDE VIA OXIDATION OF 1-CHLORO-3, 3-DIMETHYLBUTANE WITH DIMETHYL SULFOXIDE | THE NUTRASWEET COMPANY (US) | 1999-11-25 | — | — | WO | disclosed |
| US-5905175-A | Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide | THE NUTRASWEET COMPANY (US) | 1999-05-18 | — | — | US | disclosed |